Market News & Trends
Vcaps® Plus Capsules: A New HPMC Capsule for Optimum Formulation
CLICK HERE TO VIEW/DOWNLOAD DOCUMENT
Incyte Achieves $25-Million Milestone for Jakavi Approval
Incyte Corporation announced it has earned a $25-million milestone payment from Novartis in connection with the approval of Jakavi (ruxolitinib) in Japan for the treatment…
Protea Biosciences & InSphero AG Enter to Combine 3D Technologies
Protea Biosciences Group, Inc. and InSphero AG jointly announced they have entered into a collaboration that will combine each company's respective 3D technology. InSphero AG…
Oral Octreotide Could Capture a Share of Injectables Market
Recent trials exhibiting the effectiveness of oral octreotide for treating acromegaly may be a cause of concern for injectable somatostatin analogs (SSAs), providing that the…
Concept Life Sciences Creates UK-Based $100-Million Life Sciences Group
Concept Life Sciences, a newly formed international scientific laboratory and consultancy business, has made three acquisitions with a combined enterprise value approaching $100 million. The…
Logan Instruments Showcases Latest Automation System
This week, Logan Instruments Corp. is exhibiting at the CRS Annual Meeting in Chicago, IL. A leader in pharmaceutical testing instrumentation, Logan Instruments Corp. released…
AAIPharma & Cambridge Major Laboratories Announce New CEO
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. recently announced the appointment of Stephan Kutzer, PhD, as CEO, effective August 1, 2014. “AAIPharma and Cambridge…
A Tough Pill to Swallow
A Tough Pill to Swallow Patient preference and compliance are becoming increasingly important differentiators in a crowded pharmaceutical marketplace. To achieve effective product positioning and…
Constantia Flexibles Introduces Deep-Drawn Aluminum Container for Pharmaceutical Devices
Constantia Flexibles has developed a new deep-drawn aluminum container for pharmaceutical devices. Known as Constantia Safemax, the innovation offers dramatic improvement over traditional packaging in…
D3 Medicine & Viroclinicas Biosciences Sign Collaboration
d3 Medicine LLC and Viroclinics Biosciences BV recently announced they have signed a non-exclusive Memorandum of Understanding to provide biopharmaceutical customers with an integrated solution…
PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions
PolyPid recently announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for US application Serial No. 13/574,040, a…
Horizon Discovery Licenses AAV Gene Delivery Technology
Horizon Discovery Group plc recently announced it has entered into a non-exclusive license agreement with Stanford University to access intellectual property related to the use…
Catalent Marks 40 Years in Japan
Catalent Pharma Solutions, now in its 40th year in the Japanese market, recently announced that it has appointed Tadahiro Matsumura as Country Leader, Japan. In…
Antitope & Synthon Announce Collaboration
Antitope Limited recently announced it will collaborate with Synthon Biopharmaceuticals BV to assess the potential immunogenicity of candidate antibodies for Synthon’s ADC programs. Antitope…
Increased Government Efforts Aim to Reinvigorate a Stagnant Antibiotics Market
Christopher Pace, PhD, GlobalData’s Analyst covering Infectious Diseases, says “On July 1, 2014, UK Prime Minister David Cameron revealed the formation of an independent review panel…
MannKind Corporation Announces FDA Approval of Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes
MannKind Corporation (Nasdaq:MNKD) recently announced that the US Food & Drug Administration (FDA) has approved AFREZZA (insulin human) Inhalation Powder to improve glycemic control in…
Bionomics & Merck Enter New Research Collaboration
Bionomics Limited recently announced it has entered into an exclusive Research Collaboration and License Agreement with Merck, known as MSD outside the United States and…
Johnson & Johnson Innovation, Janssen Biotech & Dana-Farber Cancer Institute Launch $10-Million Collaboration
Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. recently announced a 3-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration,…
Dimension Therapeutics & Bayer Sign $252-Million Deal
Dimension Therapeutics recently announced it has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the…
Pluristem Selects Rotator Cuff Repair as New Orthopedic Indication
Pluristem Therapeutics Inc. recently announced it has selected rotator cuff repair as the second indication in its orthopedic clinical program. The company's PLacental eXpanded (PLX)…
